O	0	7	Effects
O	8	10	of
B-intervention	11	19	exercise
I-intervention	20	24	dose
O	25	28	and
O	29	33	type
O	34	40	during
O	41	47	breast
O	48	54	cancer
O	55	67	chemotherapy
O	68	70	on
O	71	77	longer
O	77	78	-
O	78	82	term
O	83	90	patient
O	90	91	-
O	91	99	reported
O	100	108	outcomes
O	109	112	and
O	113	119	health
O	119	120	-
O	120	127	related
O	128	135	fitness
O	135	136	:
O	137	138	A
O	139	149	randomized
O	150	160	controlled
O	161	166	trial
O	166	167	.

O	168	171	The
O	172	180	Combined
O	181	188	Aerobic
O	189	192	and
O	193	203	Resistance
O	204	212	Exercise
O	213	214	(
O	214	218	CARE
O	218	219	)
O	220	225	Trial
O	226	234	compared
O	235	244	different
O	245	250	types
O	251	254	and
O	255	260	doses
O	261	263	of
O	264	272	exercise
O	273	282	performed
O	283	289	during
O	290	296	breast
O	297	303	cancer
O	304	316	chemotherapy
O	316	317	.

O	318	322	Here
O	322	323	,
O	324	326	we
O	327	333	report
O	334	337	the
O	338	344	longer
O	344	345	-
O	345	349	term
O	350	356	follow
O	356	357	-
O	357	359	up
O	360	362	of
O	363	370	patient
O	370	371	-
O	371	379	reported
O	380	388	outcomes
O	388	389	,
O	390	396	health
O	396	397	-
O	397	404	related
O	405	412	fitness
O	413	416	and
O	417	425	exercise
O	426	434	behavior
O	435	437	at
O	438	439	6
O	439	440	,
O	441	443	12
O	444	447	and
O	448	450	24
O	451	457	months
O	458	474	postintervention
O	474	475	.

O	476	477	A
O	478	489	multicenter
O	490	495	trial
O	496	498	in
B-location	499	505	Canada
O	506	516	randomized
B-total-participants	517	520	301
B-eligibility	521	527	breast
I-eligibility	528	534	cancer
I-eligibility	535	543	patients
I-eligibility	544	554	initiating
I-eligibility	555	567	chemotherapy
I-eligibility	568	570	to
I-eligibility	571	577	thrice
I-eligibility	578	584	weekly
O	584	585	,
O	586	596	supervised
O	597	605	exercise
O	606	616	consisting
O	617	619	of
O	620	621	a
B-control	622	630	standard
I-control	631	635	dose
O	636	638	of
O	639	641	25
O	641	642	-
O	642	644	30
O	645	648	min
O	649	651	of
O	652	659	aerobic
O	660	668	exercise
O	669	670	(
O	670	674	STAN
O	674	675	;
O	676	677	n
O	678	679	=
O	680	682	96
O	682	683	)
O	683	684	,
O	685	686	a
O	687	693	higher
O	694	698	dose
O	699	701	of
O	702	704	50
O	704	705	-
O	705	707	60
O	708	711	min
O	712	714	of
O	715	722	aerobic
O	723	731	exercise
O	732	733	(
O	733	737	HIGH
O	737	738	;
O	739	740	n
O	741	742	=
O	743	746	101
O	746	747	)
O	748	750	or
O	751	752	a
O	753	761	combined
O	762	766	dose
O	767	769	of
O	770	772	50
O	772	773	-
O	773	775	60
O	776	779	min
O	780	782	of
O	783	790	aerobic
O	791	794	and
O	795	805	resistance
O	806	814	exercise
O	815	816	(
O	816	820	COMB
O	820	821	;
O	822	823	n
O	824	825	=
O	826	829	104
O	829	830	)
O	831	840	performed
O	841	844	for
O	845	848	the
O	849	857	duration
O	858	860	of
O	861	873	chemotherapy
O	874	875	(
O	875	881	median
O	882	884	of
O	885	887	17
O	888	893	weeks
O	893	894	)
O	894	895	.

O	896	903	Primary
O	904	912	outcomes
O	913	917	were
O	918	925	patient
O	925	926	-
O	926	934	reported
O	935	943	outcomes
O	944	953	including
B-outcome-Measure	954	961	quality
I-outcome-Measure	962	964	of
I-outcome-Measure	965	969	life
O	969	970	,
B-outcome-Measure	971	977	cancer
I-outcome-Measure	977	978	-
I-outcome-Measure	978	985	related
I-outcome-Measure	986	994	symptoms
O	995	998	and
B-outcome-Measure	999	1011	psychosocial
I-outcome-Measure	1012	1020	outcomes
O	1020	1021	.

O	1022	1031	Secondary
O	1032	1040	outcomes
O	1041	1045	were
B-outcome-Measure	1046	1055	objective
I-outcome-Measure	1056	1062	health
I-outcome-Measure	1062	1063	-
I-outcome-Measure	1063	1070	related
I-outcome-Measure	1071	1078	fitness
I-outcome-Measure	1079	1080	(
I-outcome-Measure	1080	1088	assessed
I-outcome-Measure	1089	1091	at
I-outcome-Measure	1092	1094	12
I-outcome-Measure	1095	1101	months
I-outcome-Measure	1102	1106	only
I-outcome-Measure	1106	1107	)
O	1108	1111	and
B-outcome-Measure	1112	1116	self
I-outcome-Measure	1116	1117	-
I-outcome-Measure	1117	1125	reported
I-outcome-Measure	1126	1134	exercise
I-outcome-Measure	1135	1143	behavior
O	1143	1144	.

O	1145	1146	A
O	1147	1152	total
O	1153	1155	of
B-total-participants	1156	1159	269
O	1160	1161	(
O	1161	1163	89
O	1163	1164	.
O	1164	1165	4
O	1165	1166	%
O	1166	1167	)
O	1168	1180	participants
O	1181	1190	completed
O	1191	1198	patient
O	1198	1199	-
O	1199	1207	reported
O	1208	1216	outcomes
O	1217	1219	at
O	1220	1223	all
O	1224	1229	three
O	1230	1236	follow
O	1236	1237	-
O	1237	1239	up
O	1240	1244	time
O	1245	1251	points
O	1252	1255	and
B-total-participants	1256	1259	263
O	1260	1261	(
O	1261	1263	87
O	1263	1264	.
O	1264	1265	4
O	1265	1266	%
O	1266	1267	)
O	1268	1277	completed
O	1278	1281	the
O	1282	1288	health
O	1288	1289	-
O	1289	1296	related
O	1297	1304	fitness
O	1305	1315	assessment
O	1316	1318	at
O	1319	1321	12
O	1321	1322	-
O	1322	1327	month
O	1328	1334	follow
O	1334	1335	-
O	1335	1337	up
O	1337	1338	.

O	1339	1343	COMB
O	1344	1347	was
O	1348	1361	significantly
O	1362	1370	superior
O	1371	1373	to
O	1374	1375	(
O	1375	1376	i
O	1376	1377	)
O	1378	1382	STAN
O	1383	1386	for
B-outcome	1387	1392	sleep
I-outcome	1393	1400	quality
I-outcome	1401	1403	at
I-outcome	1404	1405	6
I-outcome	1405	1406	-
I-outcome	1406	1411	month
I-outcome	1412	1418	follow
I-outcome	1418	1419	-
I-outcome	1419	1421	up
O	1422	1423	(
O	1423	1424	p
O	1425	1426	=
O	1427	1428	0
O	1428	1429	.
O	1429	1432	027
O	1432	1433	)
O	1433	1434	;
O	1435	1436	(
O	1436	1438	ii
O	1438	1439	)
O	1440	1444	HIGH
O	1445	1448	for
B-outcome	1449	1454	upper
I-outcome	1455	1459	body
I-outcome	1460	1468	muscular
I-outcome	1469	1478	endurance
I-outcome	1479	1481	at
I-outcome	1482	1484	12
I-outcome	1484	1485	-
I-outcome	1485	1490	month
I-outcome	1491	1497	follow
I-outcome	1497	1498	-
I-outcome	1498	1500	up
O	1501	1502	(
O	1502	1503	p
O	1504	1505	=
O	1506	1507	0
O	1507	1508	.
O	1508	1511	020
O	1511	1512	)
O	1512	1513	;
O	1514	1517	and
O	1518	1519	(
O	1519	1522	iii
O	1522	1523	)
O	1524	1528	HIGH
O	1529	1532	for
B-outcome	1533	1540	meeting
I-outcome	1541	1544	the
I-outcome	1545	1555	resistance
I-outcome	1556	1564	exercise
I-outcome	1565	1574	guideline
I-outcome	1575	1577	at
I-outcome	1578	1579	6
I-outcome	1579	1580	-
I-outcome	1580	1585	month
I-outcome	1586	1592	follow
I-outcome	1592	1593	-
I-outcome	1593	1595	up
O	1596	1597	(
O	1597	1598	p
O	1599	1600	=
O	1601	1602	0
O	1602	1603	.
O	1603	1606	006
O	1606	1607	)
O	1607	1608	.

O	1609	1617	Moreover
O	1617	1618	,
O	1619	1623	self
O	1623	1624	-
O	1624	1632	reported
O	1633	1640	meeting
O	1641	1643	of
O	1644	1647	the
O	1648	1656	combined
O	1657	1665	exercise
O	1666	1675	guideline
O	1676	1682	during
O	1683	1689	follow
O	1689	1690	-
O	1690	1692	up
O	1693	1696	was
O	1697	1710	significantly
O	1711	1721	associated
O	1722	1726	with
B-outcome	1727	1733	better
I-outcome	1734	1741	patient
I-outcome	1741	1742	-
I-outcome	1742	1750	reported
I-outcome	1751	1759	outcomes
I-outcome	1760	1763	and
I-outcome	1764	1770	health
I-outcome	1770	1771	-
I-outcome	1771	1778	related
I-outcome	1779	1786	fitness
O	1786	1787	.

O	1788	1798	Performing
O	1799	1807	combined
O	1808	1816	exercise
O	1817	1823	during
O	1824	1827	and
O	1828	1833	after
O	1834	1840	breast
O	1841	1847	cancer
O	1848	1860	chemotherapy
O	1861	1864	may
O	1865	1871	result
O	1872	1874	in
O	1875	1881	better
O	1882	1888	longer
O	1888	1889	-
O	1889	1893	term
O	1894	1901	patient
O	1901	1902	-
O	1902	1910	reported
O	1911	1919	outcomes
O	1920	1923	and
O	1924	1930	health
O	1930	1931	-
O	1931	1938	related
O	1939	1946	fitness
O	1947	1955	compared
O	1956	1958	to
O	1959	1969	performing
O	1970	1977	aerobic
O	1978	1986	exercise
O	1987	1992	alone
O	1992	1993	.
